# Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine

> **NCT06265415** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 60 (estimated)

## Conditions studied

- Severe Preeclampsia

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Nitroglycerine
- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT06265415
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-30
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06265415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06265415, "Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06265415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*